Latest Profitability News

Bank of Queensland has finalised the sale of its equipment finance portfolio to Challenger for $3.62 billion, marking a pivotal step in its strategic transformation. The transaction sets the stage for potential shareholder returns through a buyback and special dividend, pending approvals.

Kina Securities has successfully closed an oversubscribed PGK 235 million subordinated bond, set to list on the PNGX Debt Market on 6 May 2026, offering a fixed 7.55% coupon over ten years.

Bourns, Inc. has crossed the 90% acceptance threshold in its takeover of Rakon, making the offer unconditional and triggering compulsory acquisition rights and a planned delisting from NZX.

The Hydration Pharmaceuticals Company Limited (ASX: HPC) temporarily halted trading to relodge its FY25 Annual Report, revealing a $2.86 million loss driven by US market rationalisation and ongoing cost-cutting.

Multistack International reversed a $1.68 million loss to report a $2.26 million profit in 2025, driven by $4 million in settlement and asset disposal income. The company plans to exit its loss-making Australian operations through a share disposal while exploring new business avenues.

Fat Prophets Global Contrarian Fund (ASX: FPC) has launched an on-market buy-back of its ordinary shares, set to run from May 2026 to May 2027, signalling a fresh phase in its capital management strategy.

Jayride Group continues its pivot to a SaaS mobility platform across Australasia and Southeast Asia, managing tight cash flow and planning a capital raise to sustain operations and support ASX reinstatement.

DUG Technology Ltd recorded a 35% revenue increase in FY26-Q3, surpassing full-year FY25 revenue in just nine months and announcing a strategic move to half-year financial reporting.

Light & Wonder (ASX:LNW) posted modest revenue growth in 2025, driven by Gaming and iGaming segments, while SciPlay revenue dipped slightly. The company completed its Grover acquisition, settled a $128 million IP dispute with Aristocrat, and transitioned to a sole ASX listing.

Resmed delivered a robust Q3 FY2026 with 11% revenue growth, margin expansion, and a 21% jump in non-GAAP EPS, while announcing a new U.S. distribution centre and a $0.60 dividend.

ANZ Group Holdings Limited posted a 14% rise in cash profit for 1H26 to AUD 3.78 billion, driven by cost reductions and steady revenue, while declaring an 83-cent interim dividend with 75% franking.

Hastings Technology Metals secures 49% of a Thai hydromet plant, aiming for Q4 2026 production using African monazite feedstock, setting a path for early cash flow ahead of Yangibana.